| Date | Time | Source | Headline | Symbol | Company |
| 05/22/2008 | 4:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/22/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/19/2008 | 2:23PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/12/2008 | 7:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Baird Growth Stock Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/08/2008 | 4:57PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/08/2008 | 4:52PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/08/2008 | 9:11AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/07/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/05/2008 | 5:00PM | PR Newswire (US) | Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesit | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/02/2008 | 4:06PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2008 | 2:15PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2008 | 2:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2008 | 12:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplug | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/25/2008 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/25/2008 | 9:10AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2008 | 2:55PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2008 | 2:32PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2008 | 1:57PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2008 | 8:01AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2008 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/17/2008 | 4:57PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/17/2008 | 4:38PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/15/2008 | 5:15PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/15/2008 | 4:52PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/15/2008 | 5:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast First Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/11/2008 | 4:52PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/10/2008 | 3:05PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/10/2008 | 10:15AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/09/2008 | 4:46PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/09/2008 | 4:31PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |